Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.57 B1.58 B1.54 B1.59 B1.66 B1.64 B 6.43 B Research & development —————— — Operating income 811 M665 M410 M606 M925 M771 M 2.71 B Non-Operating Income, Total -5 M5 M8 M-3 M-3 M-13 M -11 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses -5 M5 M8 M-3 M-3 M-13 M -11 M Unusual income/expense —————— — Pretax income 759 M624 M370 M557 M872 M712 M 2.51 B Equity in earnings —————— — Taxes 308 M154 M94 M147 M172 M142 M 555 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 451 M470 M276 M410 M700 M570 M 1.96 B Discontinued operations —————— — Net income 451 M470 M276 M410 M700 M570 M 1.96 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 451 M470 M276 M410 M700 M570 M 1.96 B Basic earnings per share (Basic EPS) 2.232.341.382.073.542.91 9.9 Diluted earnings per share (Diluted EPS) 2.232.341.382.073.532.9 9.88 Average basic shares outstanding 202.9 M200.8 M199.6 M198.3 M198.9 M196.2 M 793 M Diluted shares outstanding 203.5 M201.3 M199.8 M198.5 M199.2 M196.6 M 794.1 M EBITDA 877 M741 M485 M710 M1.02 B851 M 3.06 B EBIT 790 M651 M393 M616 M921 M757 M 2.69 B Cost of revenue 5.49 B5.43 B4.83 B5.26 B5.8 B5.66 B 21.56 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 87 M90 M92 M94 M97 M94 M 377 M